JP2024511641A5 - - Google Patents

Info

Publication number
JP2024511641A5
JP2024511641A5 JP2023560277A JP2023560277A JP2024511641A5 JP 2024511641 A5 JP2024511641 A5 JP 2024511641A5 JP 2023560277 A JP2023560277 A JP 2023560277A JP 2023560277 A JP2023560277 A JP 2023560277A JP 2024511641 A5 JP2024511641 A5 JP 2024511641A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
deleted
substituted
sequence shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511641A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/058372 external-priority patent/WO2022207684A1/en
Publication of JP2024511641A publication Critical patent/JP2024511641A/ja
Publication of JP2024511641A5 publication Critical patent/JP2024511641A5/ja
Pending legal-status Critical Current

Links

JP2023560277A 2021-03-31 2022-03-30 ３－メチルクロトン酸デカルボキシラーゼ（ｍｄｃ）バリアント Pending JP2024511641A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21166368.7 2021-03-31
EP21166368 2021-03-31
PCT/EP2022/058372 WO2022207684A1 (en) 2021-03-31 2022-03-30 3-methylcrotonic acid decarboxylase (mdc) variants

Publications (2)

Publication Number Publication Date
JP2024511641A JP2024511641A (ja) 2024-03-14
JP2024511641A5 true JP2024511641A5 (cg-RX-API-DMAC10.html) 2025-03-11

Family

ID=75339587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560277A Pending JP2024511641A (ja) 2021-03-31 2022-03-30 ３－メチルクロトン酸デカルボキシラーゼ（ｍｄｃ）バリアント

Country Status (10)

Country Link
US (1) US20250320482A1 (cg-RX-API-DMAC10.html)
EP (1) EP4314269A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024511641A (cg-RX-API-DMAC10.html)
KR (1) KR20230163393A (cg-RX-API-DMAC10.html)
CN (1) CN117120604A (cg-RX-API-DMAC10.html)
AU (1) AU2022248562A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023019721A2 (cg-RX-API-DMAC10.html)
CA (1) CA3210264A1 (cg-RX-API-DMAC10.html)
IL (1) IL307259A (cg-RX-API-DMAC10.html)
WO (1) WO2022207684A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026003122A1 (en) 2024-06-26 2026-01-02 Global Bioenergies Method for producing isobutene from acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2433260A (en) 2005-12-16 2007-06-20 Mologic Ltd A selectable decarboxylase marker
CN102083990B (zh) 2008-07-04 2016-05-04 财富科学家股份有限公司 通过3-羟基烷酸的酶促脱羧制备烯
US10988752B2 (en) * 2016-05-04 2021-04-27 Global Bioenergies 3-methylcrotonic acid decarboxylase (MDC) variants
MA44868A (fr) * 2016-05-04 2019-03-13 Global Bioenergies Variantes de la décarboxylase de l'acide 3-méthylcrotonique (mdc)
EP3818155B1 (en) 2018-07-03 2023-09-06 Global Bioenergies 3-methylcrotonic acid decarboxylase (mdc) variants
EP4399284A1 (en) * 2021-09-06 2024-07-17 Global Bioenergies Organisms producing less crotonic acid

Similar Documents

Publication Publication Date Title
JP2023139129A5 (cg-RX-API-DMAC10.html)
JP2017121261A5 (cg-RX-API-DMAC10.html)
JP2005505579A5 (cg-RX-API-DMAC10.html)
NZ592009A (en) Fgf21 mutants and uses thereof
JP2018186837A5 (cg-RX-API-DMAC10.html)
AU2017286477B2 (en) Variants of a DNA polymerase of the polX family
CN110892067A (zh) 热稳定性提高的phi29DNA聚合酶突变体
JP2019519216A5 (cg-RX-API-DMAC10.html)
CN115443288A (zh) 一种免疫球蛋白降解酶IdeE的突变体
EP1801206A4 (en) PROCESS FOR THE PREPARATION OF L-ARGININE, L-ORNITHIN OR L-CITRULLINE
NZ601191A (en) Xylanases, nucleic acids encoding them and methods for making and using them
RU2014144881A (ru) Способ экспрессии полипептидов с применением модифицированных нуклеиновых кислот
JP2013520426A5 (cg-RX-API-DMAC10.html)
JP2019500414A5 (cg-RX-API-DMAC10.html)
RU2016140627A (ru) Бета-лактамазы с улучшенными свойствами для лечения
RU2017125261A (ru) Способ и промежуточные соединения для получения прегабалина
JP2013541528A5 (cg-RX-API-DMAC10.html)
JP2005502332A5 (cg-RX-API-DMAC10.html)
JP2005511038A5 (cg-RX-API-DMAC10.html)
WO2006046239B1 (en) A thymus-specific protein
KR940019726A (ko) 종양괴사인자- 알파 뮤테인
JP2008517998A5 (cg-RX-API-DMAC10.html)
JPWO2023282281A5 (cg-RX-API-DMAC10.html)
JPWO2024024806A5 (cg-RX-API-DMAC10.html)
JP2010273673A5 (cg-RX-API-DMAC10.html)